Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4+CD25+ regulatory T cells

被引:67
作者
Raghavan, S
Suri-Payer, E
Holmgren, J
机构
[1] Univ Gothenburg, Dept Med Microbiol & Immunol, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Vaccine Res Inst GUVAX, S-40530 Gothenburg, Sweden
[3] German Canc Res Ctr, Dept Tumor Immunol, Heidelberg, Vic, Australia
关键词
D O I
10.1111/j.0300-9475.2004.01447.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A Helicobacter pylori-specific in vitro coculture system was established and used to study the role of CD4(+)CD25(+) regulatory T cells (Treg) in gastritis development in mice with H. pylori infection. Effects of therapeutic immunization against H. pylori infection on the Treg function were also studied to better understand the mechanisms leading to postimmunization gastritis in these mice. Depletion of Treg led to extensive proliferation to H. pylori antigens of CD4(+) T cells isolated from either naive, H. pylori-infected or H. pylori-immunized mice. Using the Treg-depleted CD4(+) T cells from immunized mice as effector cells, we compared the suppressive efficacy of Treg isolated from naive, infected or immunized mice and found that Treg from naive mice, and slightly less efficiently from infected mice, suppressed the CD25(-) effector T-cell response and in most cases were distinctly more efficacious than Treg isolated from immunized mice. The suppressive efficacy of Treg isolated from the differently treated mice correlated closely with production of interleukin-5 (IL-5) by the Treg and suppression of interferon-gamma and IL-2 production by the CD25(-) effector T cells. Our study is the first to demonstrate in H. pylori-induced chronic infection, antigen-specific Treg with differential efficacy in suppressing H. pylori proinflammatory T effector cells.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 29 条
[1]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[2]   Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses [J].
Ermak, TH ;
Giannasca, PJ ;
Nichols, R ;
Myers, GA ;
Nedrud, J ;
Weltzin, R ;
Lee, CK ;
Kleanthous, H ;
Monath, TP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2277-2288
[3]   The disease spectrum of Helicobacter pylori:: The immunopathogenesis of gastroduodenal ulcer and gastric cancer [J].
Ernst, PB ;
Gold, BD .
ANNUAL REVIEW OF MICROBIOLOGY, 2000, 54 :615-640
[4]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[5]   Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germfree mice which is counter-regulated by CD4+CD25+ T cells [J].
Gad, M ;
Pedersen, AE ;
Kristensen, NN ;
Claesson, MH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :695-704
[6]   Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice [J].
Garhart, CA ;
Redline, RW ;
Nedrud, JG ;
Czinn, SJ .
INFECTION AND IMMUNITY, 2002, 70 (07) :3529-3538
[7]   Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation [J].
Gebert, B ;
Fischer, W ;
Weiss, E ;
Hoffmann, R ;
Haas, R .
SCIENCE, 2003, 301 (5636) :1099-1102
[8]  
Hori S, 2002, EUR J IMMUNOL, V32, P1282, DOI 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO
[9]  
2-#
[10]   Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates [J].
Johansson, EL ;
Rask, C ;
Fredriksson, M ;
Eriksson, K ;
Czerkinsky, C ;
Holmgren, J .
INFECTION AND IMMUNITY, 1998, 66 (02) :514-520